poloxalene has been researched along with Leukemia P388 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alakhov, VY; Batrakova, EV; Kabanov, AV; Kelly, DL; Li, S; Sharma, AK; Zhang, L | 1 |
Alakhov, VY; Arjakov, SA; Batrakova, EV; Dorodnych, TY; Goncharova, ON; Kabanov, AV; Klinskii, EY; Kliushnenkova, EN; Shemchukova, OB | 1 |
2 other study(ies) available for poloxalene and Leukemia P388
Article | Year |
---|---|
Prevention of MDR development in leukemia cells by micelle-forming polymeric surfactant.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Fluorescent Dyes; Genes, MDR; Inhibitory Concentration 50; Leukemia P388; Mice; Mice, Inbred Strains; Micelles; Poloxalene; Rhodamine 123; Surface-Active Agents; Xenograft Model Antitumor Assays | 2008 |
Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: in vivo evaluation of anti-cancer activity.
Topics: Animals; Antibiotics, Antineoplastic; Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Doxorubicin; Drug Carriers; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Epirubicin; Female; Leukemia P388; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Micelles; Multiple Myeloma; Neoplasm Transplantation; Poloxalene | 1996 |